ResearcherConsorci Institut D'Investigacions Biomediques August Pi I SunyerActive in the last 2 years
Marc Otero-Mateo
Matched on OpenAlex author ID A5038818066. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies in pancreatic cancer models. Co-author DOI 10.1016/j.jconrel.2026.115320↗
- KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis. Co-author DOI 10.1016/j.omton.2024.200928↗
- Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models. Co-author DOI 10.3390/cancers13133233↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cristina Fillat · 3 shared papers, 2021–2026 · strength 0.73
- Paper Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies… DOI 10.1016/j.jconrel.2026.115320↗
- Paper KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor … DOI 10.1016/j.omton.2024.200928↗
- Paper Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effe… DOI 10.3390/cancers13133233↗
- Giulia Raimondi · 1 shared paper, 2021 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.